Gemcitabine, paclitaxel, and oxaliplatin (GEMPOX) in the treatment of relapsed/refractory intracranial nongerminomatous germ cell tumors
暂无分享,去创建一个
Á. Lassaletta | L. Madero | Maria Isabel Rozas | M. Moreno-Tejero | Marta Perez-Somarriba | I. Pelaez
[1] J. Finlay,et al. Re-induction chemotherapy regimens in patients with recurrent central nervous system mixed malignant germ cell tumors , 2018, Child's Nervous System.
[2] G. Horan,et al. Current Management of Intracranial Germ Cell Tumours. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).
[3] Kaleigh Fetcko,et al. Primary Central Nervous System Germ Cell Tumors: A Review and Update. , 2018, Medical research archives.
[4] J. Mann,et al. Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial , 2017, Neuro-oncology.
[5] J. Mann,et al. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first‐line therapy , 2017, International journal of cancer.
[6] C. Bokemeyer,et al. Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group. , 2016, Urologic oncology.
[7] S. All,et al. Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature , 2016, Cureus.
[8] T. Zhou,et al. Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Soo Hyun Lee,et al. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study , 2013, Journal of Neuro-Oncology.
[10] S. Malone,et al. Successful salvage using combined radiation and ABMT for patients with recurrent CNS NGGCT following failed initial transplant , 2012, BMJ Case Reports.
[11] C. Bokemeyer,et al. Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors. , 2011, European urology.
[12] R. Coleman,et al. Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours. , 2005, Cancer treatment reviews.
[13] M. Marangolo,et al. Weekly Gemcitabine, Paclitaxel, Oxaliplatin Combination Chemotherapy in Patients With Cisplatin-Refractory Germ Cell Tumor: Preliminary Experience , 2004, American journal of clinical oncology.
[14] N. Foreman,et al. Intracranial Germ Cell Tumors: A Single Institution Experience and Review of the Literature , 2004, Journal of Neuro-Oncology.
[15] Douglas C. Miller,et al. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. Onishi,et al. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors , 2003, Cancer.
[17] C. Bokemeyer,et al. Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.